Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol for prevention of ovarian hyperstimulation syndrome in egg donors
2014-003986-11Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ovarian hyperstimulation syndrome (OHSS) comparing Resveratrol with Placebo (2 arms). Primary endpoint: VEGF levels. Started Apr 2015; status: completed.
02
Drugs
resveratrol
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on 2014-003986-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003986-11.